BioMarin Pharmaceuticals Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against BioMarin Pharmaceutical Inc. (BMRN) [MarketWatch]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: MarketWatch
December 02, 2021 (ACCESSWIRE via COMTEX) -- SAN DIEGO, CA / ACCESSWIRE / December 2, 2021 / Shareholder rights law firm Robbins LLP reminds investors of the class action on behalf of all persons and entities that purchased or otherwise acquired BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) securities between January 13, 2020 and September 3, 2021, for violations of the Securities Exchange Act of 1934. BioMarin develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. One of its product candidates is BMN 307, an AAV5 mediated gene therapy, which is in a phase 1/2 clinical trial to normalize blood phenylalanine ("Phe") concentration levels in patients with phenylketonuria ("PKU"). The Company's Phearless Phase 1/2 study is evaluating BMN 307 in adults with PKU. Image: https://www.accesswire.com/users/newswire/images/675670/7672.png If you suffered a loss due to BioMarin Pharmaceutical Inc.'s misconduct, click here BioMa
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- AAV Vectors in Gene Therapy Pipeline Landscape Report 2024: Comprehensive Insights about 70+ Companies and 235+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
- World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"PR Web
- World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders" [Yahoo! Finance]Yahoo! Finance
- First clinical trial of vosoritide for children with hypochondroplasia shows increased growth [Yahoo! Finance]Yahoo! Finance
- BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ETPR Newswire
BMRN
Earnings
- 2/22/24 - Beat
BMRN
Sec Filings
- 4/15/24 - Form 4
- 4/12/24 - Form 4
- 4/12/24 - Form 144
- BMRN's page on the SEC website